US · Healthcare

Crinetics Pharmaceuticals Inc (CRNX)

Biotechnology

Crinetics Pharmaceuticals Inc (CRNX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CRNX

P/E ratio

18.00

Crinetics Pharmaceuticals Inc (CRNX) — FAQ

What is CRNX's P/E ratio?

The price-to-earnings (P/E) ratio for Crinetics Pharmaceuticals Inc (CRNX) is 18.00 (data as of 2026-03-24).

Does Crinetics Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Crinetics Pharmaceuticals Inc (CRNX). Check the MyAverix Finance app for the latest dividend data.

What sector is Crinetics Pharmaceuticals Inc in?

Crinetics Pharmaceuticals Inc (CRNX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CRNX listed on?

CRNX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)